| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/15/2006 | CN1733007A Externally applied Chinese medicinal oil for treating skin sores and its quality control method |
| 02/15/2006 | CN1732996A Oral liquid containing nanometer grade pearl powder |
| 02/15/2006 | CN1732978A Externally applied medicine for treating vitiligo and its preparation process |
| 02/15/2006 | CN1732976A Hemostatic wound healing Dan |
| 02/15/2006 | CN1732973A Composition containing chondroitin sulfate zinc and its application |
| 02/15/2006 | CN1732972A Dextran for injection and method for preparing the same |
| 02/15/2006 | CN1732969A Ointment with clindamycin and metronidazole and method for preparing the same |
| 02/15/2006 | CN1732904A Externally applied powder |
| 02/15/2006 | CN1241912C Disulfide derivatives useful for treating allergic diseases |
| 02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |
| 02/15/2006 | CN1241659C Chinese-medicinal liniment for treating dermatopathy |
| 02/15/2006 | CN1241636C Treatment of epidermlyosis bullosa with thymosin Beta-4 |
| 02/15/2006 | CN1241629C External use medicine for treating AIDS virus |
| 02/15/2006 | CN1241628C Oral medication for treating psoriasis |
| 02/15/2006 | CN1241617C Composite medicine composition for treating acne and spots and its preparing process |
| 02/15/2006 | CN1241595C Spray for burn and scald |
| 02/15/2006 | CN1241594C Skin external sterilizer |
| 02/15/2006 | CN1241590C Ointment for treating burns and scalds and its preparation |
| 02/15/2006 | CN1241589C Medicine for treating teen-ager's leukotrichia |
| 02/15/2006 | CN1241583C Fermented soybean extracted liquid and composite medicine containing the said liquid |
| 02/15/2006 | CN1241578C Skin-care medicine with functions of relieving-itching, eliminating-toxins and curing-tinea, and its preparation method |
| 02/15/2006 | CN1241577C Medicine use of cyclodextrin derivatives and medicine composition thereof |
| 02/15/2006 | CN1241542C 乳化组合物 Emulsified composition |
| 02/15/2006 | CN1241540C Cosmetic composition comprising human serum albumin obtained from transgenic non-human animals |
| 02/15/2006 | CN1241536C Humectant and cosmetics and external preparation containing the same |
| 02/15/2006 | CN1241534C Cosmetic skin care compositions containing cumic alcohol |
| 02/14/2006 | US6998503 crystallized as an anhydrous, stoichiometric 1.5 HCl salt; inhibiting or modulating nitric oxide synthesis |
| 02/14/2006 | US6998426 Oil in water emulsion |
| 02/14/2006 | US6998416 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/14/2006 | US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic |
| 02/14/2006 | US6998263 Methods of preparing and using a viral vector library |
| 02/14/2006 | US6998244 contacting a cell transformed or transfected with an expression vector capable of expressing 5-HT4 receptor with a compound in presence of a ligand, monitoring CAMP formation in the cell, a change indicates compund as an antagonist or agonist |
| 02/14/2006 | US6998129 Comprises association between elastase inhibitor compound of the N-acylaminoamide family and at least one antiinflammatory compound; for improving skin ageing and/or photoageing signs by slowing down connective tissue alterations |
| 02/14/2006 | CA2374643C 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists |
| 02/14/2006 | CA2363145C Oxamic acids and derivatives as thyroid receptor ligands |
| 02/14/2006 | CA2269072C Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/14/2006 | CA2245197C Unsaturated derivatives in position -4 of 6-tert-butyl-1, 1-dimethylindan and their use in human or veterinary medicine and in cosmetics |
| 02/09/2006 | WO2006014157A1 Methods of using regenerative cells to promote wound healing |
| 02/09/2006 | WO2006014100A1 Pharmaceutical formulation of herbal medicines based on phytolacca americana, alnus acuminata extracts and coal tar for treating and curing psoriasis |
| 02/09/2006 | WO2006013963A1 External preparation for nail |
| 02/09/2006 | WO2006013948A1 Triazole derivative |
| 02/09/2006 | WO2006013873A1 Drugs having cyclooxygenase inhibiting activity |
| 02/09/2006 | WO2006013472A2 Novel anti-igf-ir antibodies and uses thereof |
| 02/09/2006 | WO2005094778B1 Cosmetic and/or dermatological preparation and use thereof in the regulation of skin capillary blood flow |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | US20060030900 Two-phase oxygenated solution and method of use |
| 02/09/2006 | US20060030655 Nanoemulsion containing nonionic polymers, and its uses |
| 02/09/2006 | US20060030626 Method of treating autoimmune diseases |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030605 Pharmaceutical compounds |
| 02/09/2006 | US20060030604 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 02/09/2006 | US20060030598 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 02/09/2006 | US20060030580 Contacting phenolic piperidines with opioid receptors; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction |
| 02/09/2006 | US20060030576 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| 02/09/2006 | US20060030568 Crystal modificaion of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use |
| 02/09/2006 | US20060030561 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 02/09/2006 | US20060030560 Pyrimidine compounds |
| 02/09/2006 | US20060030557 Substituted pyridines having antiangiogenic activity |
| 02/09/2006 | US20060030005 C3b/C4b complement receptor-like molecules and uses thereof |
| 02/09/2006 | US20060029689 Skin protection composition |
| 02/09/2006 | US20060029687 comprises a carrier essentially formed of water, ethoxydiglycol and propylene glycol; anti-oxidant; high stirring speed provides for micronizaton of the components, which is responsible for the stability of the solutions |
| 02/09/2006 | US20060029682 Treatment of wounds and compositions employed |
| 02/09/2006 | US20060029638 Methods for treating body tissue |
| 02/09/2006 | US20060029627 Antipruritic composition and wound-healing-promoting composition |
| 02/09/2006 | US20060029623 Invert emulsions comprising at least one active agent sensitive to water and cosmetic/dermatological applications thereof |
| 02/09/2006 | US20060029556 Aqueous-alcoholic depigmenting gels |
| 02/09/2006 | US20060026775 Administering N-Phenyl-2({[(1Z)-1-(thien-2-yl)-ethylidene]amino}oxy)acetamide for inducing and/or stimulating the growth of keratinous fibers and/or slowing the loss and/or increasing the density thereof, notably human hair and/or eyelashes |
| 02/09/2006 | DE69717294C5 Chinazolin derivate und diese enthaltende pharmazeutische zusammenstellungen Quinazoline derivatives and those containing pharmaceutical assortments |
| 02/09/2006 | DE102004031210A1 MLV-Kosmetikum MLV cosmetic |
| 02/09/2006 | CA2638747A1 Combination drug therapy for reducing scar tissue formation |
| 02/09/2006 | CA2575348A1 Novel anti-igf-ir antibodies and uses thereof |
| 02/09/2006 | CA2572113A1 Methods of using regenerative cells to promote wound healing |
| 02/09/2006 | CA2571647A1 Composition comprising natural substances having healing, repellent and biocidal properties for the treatment and the cure of external wounds |
| 02/08/2006 | EP1623984A1 Polymorphic form I of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/08/2006 | EP1623741A2 Cannabinoid receptor ligands for hair growth modulation |
| 02/08/2006 | EP1623718A1 Skin collagen production promoter |
| 02/08/2006 | EP1623710A1 Receptor antagonist |
| 02/08/2006 | EP1622627A1 Pharmaceutical compositions comprising cereal beta(1-3) beta(1-4) glucan |
| 02/08/2006 | EP1622614A2 Use of a topical medicament comprising riluzole |
| 02/08/2006 | EP1622596A1 Insoluble globin injectable implant |
| 02/08/2006 | EP1622579A2 Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin |
| 02/08/2006 | EP1622554A1 Compositions containing a combination of a pharmaceutical agent or a cosmetic agent and an oxy group-bearing aromatic aldehyde |
| 02/08/2006 | EP1478393A4 Anti-pathogen treatements |
| 02/08/2006 | EP1423082A4 Plasma protein matrices and methods for their preparation |
| 02/08/2006 | EP1358162B1 Dihydroindole and tetrahydroquinoline derivatives |
| 02/08/2006 | EP1187815B1 4-phenyl-pyrimidine derivatives |
| 02/08/2006 | EP1144348B1 Lta 4 hydrolase inhibitors |
| 02/08/2006 | CN1732182A Peptides and medicinal compositions containing the same |
| 02/08/2006 | CN1731972A Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines |
| 02/08/2006 | CN1731970A Cosmetic oil-in-water emulsion preparation |
| 02/08/2006 | CN1730076A Oral liquid for curing burn and process for preparing the same |
| 02/08/2006 | CN1730049A Ointment for treating burn and its preparing process |
| 02/08/2006 | CN1730036A Liquid for cleaning burn wound and its preparation process |
| 02/08/2006 | CN1730035A Externally applied spray for summer boil and miliaria |
| 02/08/2006 | CN1730014A Novel drug administration route of semen armeniacae amarum injection, its preparation process and new indications |
| 02/08/2006 | CN1729986A Anti-scar drug film and its preparing method |
| 02/08/2006 | CN1240836C Transforming growth factor alpha HI |
| 02/08/2006 | CN1240688C Quinazoline compounds |
| 02/08/2006 | CN1240408C Ointment for treating chilblain |
| 02/08/2006 | CN1240395C Medicine for treating bromhidrosis |